DPI device availability is limited to "controller" medications ... considerations in the selection of inhaler devices for elderly patients with COPD in the outpatient setting and provides ...

In terms of COPD, it is more difficult to describe what poor control looks like ... especially in relation to finding an inhaled therapy that the patient can actually take. In other words there ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

The potential applications of inhaled GSH are numerous when one considers just how many pulmonary diseases and ... with or without double-blind placebo control. B Systematic reviews of ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions under Part D or Medicare Advantage (Part C) plans. With Medicare coverage, you may still have ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...